Drug Trial Radar · NCT06799247
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
128
Actual
Start
May 6, 2025
Primary completion
Dec 30, 2026
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Cartesian TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylcholine receptor autoantibody -positive generalized myasthenia gravis. Part 1 of the study will last around 6 months. For eligible participants, Part 2 will last around 8 months.
Conditions
- Myasthaenia Gravis
Interventions
Decartes-08Biological
Autologous mRNA CAR T-cell therapy
Placebo DrugOther
infusion without Decartes-08
Primary outcomes
What the sponsor says the trial is designed to measure.
- Myasthenia Gravis Activities of Daily Living (MG-ADL)Time frame: assessment at 4 months of study
Locations
34 sites in 8 countries. Site status is shown where the registry gives one.
A40
Tucson, Arizona
A13
Carlsbad, California
A46
Los Angeles, California
A14
Orange, California
A21
Aurora, Colorado
A50
Washington D.C., District of Columbia
A48
Maitland, Florida
A10
Tampa, Florida
A53
O'Fallon, Illinois
A20
Fairway, Kansas
A16
Lexington, Kentucky
A38
Boston, Massachusetts
A12
Amherst, New York
A52
New York, New York
A47
New York, New York
A22
Chapel Hill, North Carolina
A39
Charlotte, North Carolina
A15
Portland, Oregon
A11
Philadelphia, Pennsylvania
A49
Pittsburgh, Pennsylvania
A43
Houston, Texas
A41
Seattle, Washington
A54
Milwaukee, Wisconsin
A18
Toronto, Canada
A23
Rome, Italy
A30
Krakow, Poland
A24
Belgrade, Serbia
A25
Barcelona, Spain
A26
Barcelona, Spain
A31
Madrid, Spain
A32
Ankara, Turkey (Türkiye)
A17
Istanbul, Turkey (Türkiye)
A33
Birmingham, United Kingdom
A51
Sheffield, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.